An automated clinical decision support system (CDSS) tailored for immunization in pediatric oncology patients has been developed and evaluated to address the complex vaccination needs of children undergoing cancer treatment. Recently, a research team from Poland and Germany published a study in the International Journal of Medical Informatics, reporting on the development and evaluation of an automated clinical decision support system (CDSS) specifically designed for pediatric oncology patients.
Chemotherapy and other cancer therapies can induce prolonged immunosuppression, often lasting up to 12 months after treatment, disrupting routine vaccination schedules and creating a need for individualized catch-up strategies. However, existing immunization decision-support tools are primarily designed for healthy populations and lack rules for oncology-specific scenarios such as chemotherapy-related contraindications, hematopoietic stem cell transplantation (HSCT) requiring revaccination, and timing of live vaccines. As a result, vaccination planning for pediatric cancer survivors is typically performed manually, which is time-consuming, error-prone, and highly dependent on specialist expertise.
To address these gaps, the CDSS that generates personalized vaccination schedules for pediatric oncology patients. The system was built through a systematic review of immunization recommendations and integration of guidance from multiple authoritative sources, including WHO- and ACIP-aligned recommendations. The resulting knowledge base covers 27 vaccines and incorporates key parameters such as age-specific dose requirements, minimum and optimal intervals, contraindications for live vaccines during chemotherapy, post-treatment waiting periods, and revaccination strategies following HSCT. The algorithm produces individualized schedules through a structured six-step process, including verification of vaccination history, determination of required doses, timeline generation, application of vaccine-specific rules, incorporation of booster requirements, and optimization based on combination vaccine preferences.
Technical validation compared algorithm-generated schedules with expert-developed plans across 15 representative clinical scenarios, including common pediatric malignancies and special non-oncology cases. The system demonstrated 100% accuracy in vaccine selection and complete agreement with expert recommendations regarding vaccination timing within acceptable guideline windows. The tool also handled complex HSCT-related revaccination scenarios reliably and generated schedules within two seconds, indicating strong computational efficiency.
A prospective user evaluation involving 57 healthcare professionals further demonstrated clinical utility. Most participants used the tool in outpatient settings, primarily for verifying vaccination plans, generating schedules, and reviewing immunization histories. Users reported a median time saving of 20 minutes per schedule, and the system achieved a median usability score of 4.5 out of 5, with no significant scheduling errors observed during evaluation. These findings suggest that the CDSS can be effectively integrated into routine clinical workflows and may improve both efficiency and accuracy of immunization management for pediatric cancer patients.
Future improvements of the CDSS may include automated rule integration and natural language processing–based approaches for semi-automated guideline incorporation. Overall, this study demonstrates that an automated CDSS can standardize and streamline vaccination planning for pediatric oncology populations, potentially improving access to appropriate immunization and reducing missed or delayed vaccinations, particularly in settings with limited specialist expertise.
Currently, China lacks systematic vaccination guidelines for pediatric oncology patients, with limited coverage of tumor-specific scenarios and significant knowledge gaps among frontline providers. The development and implementation of the automated clinical decision support system reported in this study may serve as a valuable reference for creating similar tools to facilitate timely routine and catch-up vaccinations for children with cancer in less developed regions of China.
Content Editor: Tianyi Deng
Page Editor: Ruitong Li
The Original Study Paper:
Wawrzuta, D., Giefert, S., & Klejdysz, J. (2025). Optimizing immunization in pediatric oncology: Development and evaluation of an automated scheduling tool. International Journal of Medical Informatics, 201, 105950. https://doi.org/10.1016/j.ijmedinf.2025.105950
Supplementary References:
1. Arzt, N. H. (2016). Clinical decision support for immunizations (CDSi): A comprehensive, collaborative strategy. Biomedical Informatics Insights, 8(Suppl. 2), 1–13. https://doi.org/10.4137/BII.S40204
2. National Health Commission of the People’s Republic of China. (2021, February 23). 国家卫生健康委关于印发国家免疫规划疫苗儿童免疫程序及说明（2021年版）的通知 [Notice on issuing the national immunization program schedule and instructions for children (2021 edition)]. https://www.nhc.gov.cn/wjw/c100175/202103/951e284920bd4a908ba10875694f0f0e.shtml
3. Shrader, L., Myerburg, S., & Larson, E. (2020). Clinical decision support for immunization uptake and use in immunization health information systems. Online Journal of Public Health Informatics, 12(1), e10. https://doi.org/10.5210/ojphi.v12i1.10602
